Riskpilot← Back to searchSign inGet full accessBROW REHAB AS
ASActiveOrg 918652507Thereses Gate 39, 0354 OsloWholesale of perfume and cosmetics · NACE 4645Est. 20170 employees
Revenue 2024
NOK 0
EBITDA margin
—
-39% vs 2023
Equity ratio
-56.2%
Financial strength
Net profit 2024
NOK -102K
-37% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -59K | -39% |
| Net profit | NOK -102K | -37% |
| Total assets | NOK 787K | +1% |
| Equity | NOK -442K | -30% |
| Employees | 0 | — |
Legal name
BROW REHAB AS
Org number
918652507
Legal form
Aksjeselskap
NACE code
4645 · Wholesale of perfume and cosmetics
Founded
3. mars 2017
Share capital
NOK 60 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene. Styrets leder alene.
Company purpose
Investerings i aksjer, eiendom og andre verdipapirer, herunder å delta i andre selskap med lignende virksomhet, eller på annen måte gjøre seg interessert i andre foretak.
Address
Thereses Gate 39, 0354 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −265 | −32 | −33 | −43 | −59 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −265 | −32 | −33 | −43 | −59 |
| Net financials | −429 | 2 | −6 | −32 | −43 |
| Profit before tax | −694 | −30 | −39 | −75 | −102 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −694 | −30 | −39 | −75 | −102 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 747 | 788 | 797 | 782 | 787 |
| Equity | −196 | −227 | −266 | −340 | −442 |
| Long-term debt | 443 | 0 | 0 | 0 | 0 |
| Short-term debt | 500 | 1 015 | 1 063 | 1 122 | 1 229 |
| Total debt | 943 | 1 015 | 1 063 | 1 122 | 1 229 |
EBITDA margin
-5943000.0%
This company
15.8%
Market median
-37614024% vs market
20202024
Equity ratio
-56.2%
This company
38.2%
Market median
-247% vs market
20202024
Return on equity
-10201900.0%
This company
18.4%
Market median
-55445209% vs market
20202024
Net profit margin
-10201900.0%
This company
8.1%
Market median
-125949483% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
2.78×
This company
0.62×
Market median
-348% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SL Chief Executive Officer | Chief Executive Officer | 2017 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Montenor Holding As
BROW REHAB AS Board members of BROW REHAB AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Silje Lyngstad | Chief Executive Officer | 0 companies |
| Arve Tormod Noreng | Chairman | 0 companies |
| Tormod Noreng | Board of Directors | 0 companies |